This is the first time that this type of scientific method has been used to detect polio
News
NICE recommends Amryt’s Filsuvez for rare skin disorder
Around 670 people in England with epidermolysis bullosa will benefit from the treatment
Alligator Bioscience gains orphan designation for mitazalimab
Mitazalimab is a monoclonal antibody that has been created to sensitize tumours to chemotherapy
LEO receives marketing authorisation application for delgocitinib
The treatment is indicated for adults with moderate-to-severe chronic hand eczema
Men with enlarged prostates offered robotic treatment by fourth University Hospital
Aquablation is a robotic method that uses a high-pressure saline solution to remove tissue
EIP Pharma merges with CervoMed
The amalgamated company will focus on advancing neflamapimod for the treatment of dementia
NICE gives green light for MSD’s Keytruda
The decision is the first verdict based on data from a wider immunotherapy ‘basket’ study
Elfabrio receives vital MHRA authorisation
The therapy involves long-term enzyme replacement therapy for aduls with Fabry disease
NIH and Exothera in partnership to produce COVID-19 vaccine
The new vaccine is an alternative to injected versions and no medical training is needed to deliver it
Chiesi forms tech partnership with Aliada
The collaboration will focus on multiple enzyme cargoes modified using Aliada’s modular delivery platform
Calliditas reveals results from vital NefIgArd study
The study concerns the use of Nefecon among adult patients with primary IgA nephropathy
Evgen releases data from SFX-01 trial
The study is specifically analysing the company’s new enteric coated tablet formation of the drug
CymaBay begins phase 3 liver disease study
IDEAL study aims to determine the impact of seladelpar on alkaline phosphatase levels
CNX acquires four cancer drugs from Clinigen
The purchased therapies concerned are Cardioxane, Totect, Ethyol and Savene
Novartis’ remibrutinib shows promise for patients with CSU
Highly selective inhibitor therapy treats patients with chronic spontaneous urticaria
